Nimulid efficacy and tolerability in patients with rheumatic diseases
| Autor: | R M Balabanova, T P Grishaeva, O V Siepaneis |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2004 |
| Předmět: | |
| Zdroj: | Научно-практическая ревматология, Vol 42, Iss 1, Pp 48-50 (2004) |
| Druh dokumentu: | article |
| ISSN: | 1995-4484 1995-4492 |
| DOI: | 10.14412/1995-4484-2004-1383 |
| Popis: | Objective. To study efficacy and safety of nimulid. Material and Methods. 33 pts with different rheumatic and vascular diseases were included in an open clinical trial of nimulid. Nimulid was administered 100-200 mg/day during 30 days. Disease modifying therapy was remained unchanged. Clinical and laboratory parameters were assessed before the start and after the end of therapy. Results. Significant improvement of all joint symptoms was achieved. 22(66,6%) pts showed good and 11(33,3%) - fair effect. Adverse events revealed in 5(7%) pts were mild and did not lead to the drug withdrawal. All adverse events were completely reversible. Conclusion. Our data show high efficacy and good tolerability of nimulid in this pts category. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|